Your browser doesn't support javascript.
loading
Population pharmacokinetic and pharmacodynamic modeling of capecitabine and its metabolites in breast cancer patients.
Lunar, Nastja; Etienne-Grimaldi, Marie-Christine; Macaire, Pauline; Thomas, Fabienne; Dalenc, Florence; Ferrero, Jean-Marc; Pivot, Xavier; Milano, Gérard; Royer, Bernard; Schmitt, Antonin.
Afiliação
  • Lunar N; Pharmacy Department, Centre Georges-François Leclerc, 1 rue Pr Marion, 21079, Dijon Cedex, France.
  • Etienne-Grimaldi MC; INSERM U1231, University of Burgundy Franche-Comté, Dijon, France.
  • Macaire P; Centre Antoine-Lacassagne, 33, avenue de Valombrose, 06189, Nice cedex 2, France.
  • Thomas F; Groupe de Pharmacologie Clinique & Oncologique (GPCO)-Unicancer, 101 rue de Tolbiac, 75013, Paris, France.
  • Dalenc F; Pharmacy Department, Centre Georges-François Leclerc, 1 rue Pr Marion, 21079, Dijon Cedex, France.
  • Ferrero JM; INSERM U1231, University of Burgundy Franche-Comté, Dijon, France.
  • Pivot X; Groupe de Pharmacologie Clinique & Oncologique (GPCO)-Unicancer, 101 rue de Tolbiac, 75013, Paris, France.
  • Milano G; ICR, IUCT-Oncopole, Toulouse, France.
  • Royer B; Université de Toulouse, CRCT, Inserm UMR1037, 31000, Toulouse, France.
  • Schmitt A; ICR, IUCT-Oncopole, Toulouse, France.
Cancer Chemother Pharmacol ; 87(2): 229-239, 2021 02.
Article em En | MEDLINE | ID: mdl-33386926
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Capecitabina / Modelos Biológicos / Antimetabólitos Antineoplásicos Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Capecitabina / Modelos Biológicos / Antimetabólitos Antineoplásicos Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França